Study on the Incidence of Malignant Neoplasms in Patients With Parkinson's Disease and Heterozygous Mutation of the GBA Gene | MicrobiomeTrials← Back to trialsNCT06814431
Study on the Incidence of Malignant Neoplasms in Patients With Parkinson's Disease and Heterozygous Mutation of the GBA Gene
RecruitingOBSERVATIONAL
Trial Details
Start: 2023-11-23Est. Completion: 2026-12
Enrollment target: 3,000 participants Locations- Ospedale A. Perrino, Brindisi, Italy
- IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
- Azienda USL IRCCS di Reggio Emilia, Reggio Emilia, Italy
- Ospedale Santa Chiara di Trento, Trento, Italy
Other microbiome trials you might be interested in
PARKINSON DISEASE (Disorder)
This protocol describes a randomized, controlled, parallel-group, trial evaluating the effectiveness of a group-based fa…
Genova, ItalyEst. completion Jun 1, 2026
Parkinson's Disease (PD)
Impulse control disorders (ICDs) are frequently observed in Parkinson's disease (PD) and can have a major functional imp…
Clermont-Ferrand, FranceEst. completion Jan 1, 2028